title: Pheochromocytoma.
authors.affiliation: Department of Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic, Barcelona, Spain. lfcruz@clinic.ub.es
authors.forename: L
authors.initials: L
authors.lastname: Fernández-Cruz
authors.forename: M
authors.initials: M
authors.lastname: Puig-Domingo
authors.forename: I
authors.initials: I
authors.lastname: Halperin
authors.forename: G
authors.initials: G
authors.lastname: Sesmilo
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000601:surgery*; D000311:Adrenal Glands / Q000000981:diagnostic imaging / Q000187:drug effects / Q000601:surgery; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003131:Combined Modality Therapy; D017292:Doxazosin / Q000627:therapeutic use; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D008279:Magnetic Resonance Imaging; D009154:Mutation; D010673:Pheochromocytoma / Q000188:drug therapy / Q000235:genetics / Q000601:surgery*; D014057:Tomography, X-Ray Computed; D019805:alpha-Methyltyrosine / Q000627:therapeutic use
chemical_list: D002121:Calcium Channel Blockers; D019805:alpha-Methyltyrosine; D017292:Doxazosin